CAPRICOR THERAPEUTICS, INC.·4

Apr 3, 5:00 PM ET

Sabar Karimah Es 4

4 · CAPRICOR THERAPEUTICS, INC. · Filed Apr 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Capricor (CAPR) Director Sabar Karimah Exercises and Sells Shares

What Happened

  • Director Sabar Karimah exercised/conversion of a derivative for 7,529 shares (recorded as an "M" transaction) at $3.18 per share (total cost $23,942) and immediately sold those 7,529 shares in an open-market sale at $32.00 per share for $240,928 on 2026-04-02. The filing also records the corresponding disposition of the derivative instrument (7,529 shares, $0.00 value).
  • This is a sale of shares following an exercise/conversion — typically routine insider liquidity rather than a new purchase (not a bullish purchase signal).

Key Details

  • Transaction date: April 2, 2026; Form 4 filed April 3, 2026 (timely).
  • Exercise/Acquisition: 7,529 shares @ $3.18 = $23,942 (transaction code M).
  • Sale/Disposition: 7,529 shares @ $32.00 = $240,928 (transaction code S).
  • Net proceeds before taxes/fees (proceeds minus exercise cost): roughly $216,986.
  • Footnotes: F1 — shares sold pursuant to a 10b5-1 trading plan adopted Dec 2025; F2 — shares vested 1/48th on the first day of each month beginning Feb 1, 2022.
  • Shares owned after transaction: not specified in the excerpt of the filing provided.

Context

  • For derivative transactions: this filing shows an option/derivative was exercised (incurring the $3.18 per-share cost) and the resulting shares were sold in the open market — effectively a cash exercise followed by immediate sale under a pre-existing 10b5-1 plan.
  • The 10b5-1 plan note indicates the sale followed a pre-set trading plan (reduces concerns about opportunistic timing).
  • No indication this was a gift or a related-party/10% owner transaction in the provided data.

Insider Transaction Report

Form 4
Period: 2026-04-02
Transactions
  • Exercise/Conversion

    Common Stock

    2026-04-02$3.18/sh+7,529$23,9427,529 total
  • Sale

    Common Stock

    [F1]
    2026-04-02$32.00/sh7,529$240,9280 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F2]
    2026-04-027,529161 total
    Exercise: $3.18Exp: 2032-01-03Common Stock (7,529 underlying)
Footnotes (2)
  • [F1]Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • [F2]Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Signature
/s/ Linda Marban, Attorney-in-Fact|2026-04-03

Documents

1 file
  • 4
    form4-04032026_050401.xmlPrimary